Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 12/2016

01-12-2016 | Retraction Note

Retraction Note to: Urinary parameters predictive and electrolyte disturbances of cisplatin-induced acute renal associated with cancer as a critical target of the chemotherapeutic agent in patients with solid tumors

Authors: Behnam Pedram, Ahmad Taghavi Moghadam, Zahra Kamyabi-Moghaddam, Omid Mavedati, Babak Abbas Beigi, Adel Khodaei Sharabiyani, Ali Bashiri Dezfuli, Soheil Khalili, Ali Mohammad Bahrami, Alireza Nasoori

Published in: Tumor Biology | Issue 12/2016

Login to get access

Excerpt

Retraction Note to: Tumor Biol (2015) 36:4495–4500 …
Metadata
Title
Retraction Note to: Urinary parameters predictive and electrolyte disturbances of cisplatin-induced acute renal associated with cancer as a critical target of the chemotherapeutic agent in patients with solid tumors
Authors
Behnam Pedram
Ahmad Taghavi Moghadam
Zahra Kamyabi-Moghaddam
Omid Mavedati
Babak Abbas Beigi
Adel Khodaei Sharabiyani
Ali Bashiri Dezfuli
Soheil Khalili
Ali Mohammad Bahrami
Alireza Nasoori
Publication date
01-12-2016
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 12/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-016-5476-1

Other articles of this Issue 12/2016

Tumor Biology 12/2016 Go to the issue

Original Article

Association of single-nucleotide polymorphisms of high-mobility group box 1 with susceptibility and clinicopathological characteristics of uterine cervical neoplasia in Taiwanese women

Original Article

Sonic hedgehog signaling pathway mediates development of hepatocellular carcinoma

Original Article

RAD51 regulates CHK1 stability via autophagy to promote cell growth in esophageal squamous carcinoma cells

Original Article

Cancer/testis antigens as molecular drug targets using network pharmacology

Original Article

Effects and mechanisms of action of SARI on androgen-independent prostate cancer (DU145) cells

Original Article

RETRACTED ARTICLE: Regulation of activating protein-4-associated metastases of non-small cell lung cancer cells by miR-144
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits